China's State FDA Aims To Test All National Essential Drugs By Year's End
This article was originally published in PharmAsia News
Executive Summary
At a recent conference on the sample testing of national essential drugs held in Wuhan, Chinese State FDA Deputy Commissioner Bian Zhenjia requested that the country's regional FDA offices accelerate efforts to ensure completion of sample-testing all national essential drugs in regulated areas by the year's end